Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation

JAMA - Journal of the American Medical Association

Volumn 314, Issue 10, 2015, Pages E1-E9

  Melgaard, Line ^a   Gorst Rasmussen, Anders ^a,b   Lane, Deidre A ^c   Rasmussen, Lars Hvilsted ^a   Larsen, Torben Bjerregaard ^a   Lip, Gregory Y H ^a,c  

^a AALBORG UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE ASSESSMENT; CHA2DS2 VASC SCORE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; POPULATION RISK; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; COMPLICATION; DENMARK; DIABETES MELLITUS; INTERNATIONAL CLASSIFICATION OF DISEASES; PROSPECTIVE STUDY; SEX DIFFERENCE; STROKE;

AGED; ATRIAL FIBRILLATION; DENMARK; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STROKE; THROMBOEMBOLISM;

EID: 84941625442     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.10725     Document Type: Article

References (33)

1. Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN. Incidence of thromboembolic events in congestive heart failure: the V-HeFT VA Cooperative Studies Group. Circulation. 1993;87(6) (suppl):VI94-VI101.
2. Alberts VP, Bos MJ, Koudstaal P, et al. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol. 2010;25(11):807-812.
3. Freudenberger RS, Hellkamp AS, Halperin JL, et al; SCD-HeFT Investigators. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2007;115(20):2637-2641.
4. Lip GY, Rasmussen LH, Skjøth F, Overvad K, Larsen TB. Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open. 2012;2(4):1-10.
5. Agarwal M, Apostolakis S, Lane DA, Lip GYH. The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboem-bolism, and mortality in atrial fibrillation patients: a systematic review. Clin Ther. 2014;36(9):1135-1144.
6. Camm AJ, Lip GY, De Caterina R, et al; ESC Committee for Practice Guidelines. 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33(21):2719-2747.
7. January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64(21):e1-e76.
8. Lip GYH, Lin H-J, Chien K-L, et al. Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study. IntJ Cardiol. 2013;168(1): 414-419.
9. 2-VASc scores. Heart. 2014;100(19):1524-1530.
10. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347(18): 1397-1402.
11. Forman DE, Ahmed A, Fleg JL. Heart failure in very old adults. Curr Heart Fail Rep. 2013;10(4):387-400.
12. 2-VASc>1, or higher? Thromb Haemost. 2015;113(6):1165-1169.
13. Nielsen PB, Chao TF. The risks of risk scores for stroke risk assessment in atrial fibrillation. Thromb Haemost. 2015;113(6):1170-1173.
14. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7)(suppl):30-33.
15. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7)(suppl):38-41.
16. Pedersen CBC. The Danish Civil Registration System. Scand J Public Health. 2011;39(7)(suppl): 22-25.
17. Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T. Validity of stroke diagnoses in a national register of patients. Neuroepidemiology. 2007;28 (3):150-154.
18. Kümler T, Gislason GH, Kirk V, et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008;10(7):658-660.
19. Frost L, Andersen LV, Vestergaard P, Husted S, Mortensen LS. Trend in mortality after stroke with atrial fibrillation. Am J Med. 2007;120(1):47-53.
20. Camm AJ, Kirchhof P, Lip GY, et al; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery; ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10): 1360-1420.
21. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706.
22. Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics. 2005;61 (1):223-229.
23. Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Stat Med. 2007;26(24):4505-4519.
24. Jacqmin-Gadda H, Blanche P, Chary E, Loubère L, Amieva H, Dartigues JF. Prognostic score for predicting risk of dementia over 10 years while accounting for competing risk of death. Am J Epidemiol. 2014;180(8):790-798.
25. Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381-5397.
26. Witt BJ, Brown RD Jr, Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study. Am Heart J. 2006;152(1): 102-109.
27. Melgaard L, Gorst-Rasmussen A, Lip GYH, Rasmussen LH, Larsen TB. Female sex is associated with a lower risk of stroke in patients with heart failure. Am Heart J. 2015;169(3):396-403.e2.
28. Lip GY, Piotrponikowski P, Andreotti F, et al; Heart Failure Association of the European Society of Cardiology; ESC Working Group on Thrombosis. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Thromb Haemost. 2012;108(6):1009-1022.
29. Homma S, Thompson JLP, Pullicino PM, et al; WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366(20):1859-1869.
30. Lip GYH, Shantsila E. Anticoagulation vs placebo for heart failure in sinus rhythm. Cochrane Database Syst Rev. 2014;3:CD003336.
31. Eckman MH, Singer DE, Rosand J, Greenberg SM. Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2011;4(1):14-21.
32. Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GYH. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study. Circ Arrhythm Electrophysiol. 2012;5(2):319-326.
33. 2-VASc score = 0 in a community-based cohort study. J Cardiovasc Electrophysiol. 2012;23 (7):708-713.